The use of mutation-specific antibodies in predicting the effect of EGFR-TKIs in patients with non-small-cell lung cancer.
Zhao J, Wang X, Xue L, Xu N, Ye X, Zeng H, Lu S, Huang J, Akesu S, Xu C, He D, Tan Y, Hong Q, Wang Q, Zhu G, Hou Y, Zhang X.
Zhao J, et al. Among authors: zhang x.
J Cancer Res Clin Oncol. 2014 May;140(5):849-57. doi: 10.1007/s00432-014-1618-2. Epub 2014 Feb 22.
J Cancer Res Clin Oncol. 2014.
PMID: 24562619